In a study of healthy infants, researchers discover exposure to C. difficile in infancy may provide natural immunization later in childhood.
Browsing: Clinical > Vaccines
Researchers from the University of Texas at Austin have passed an experimental RSV vaccine through Phase I human clinical trial with promising results.
Take a look at this month’s industry headlines including a US FDA approval for RECARBRIO™, positive results for XOFLUZA in children and new ACIP recommendations.
A DNA vaccine for MERS-CoV was demonstrated to be well-tolerated and immunogenic in a Phase I, first-in-human trial.
New research has revealed a dangerous stagnation in the global vaccination rates of children, owing to inequality, conflict and complacency.
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new funding for chikungunya vaccine clinical…
A new meta-analysis including data from 60 million individuals over 8 years has demonstrated significant decreases in HPV infections, anogenital wart diagnoses and precancerous cervical lesions following HPV vaccination in girls.
New study determines a neutralizing antibody which binds to the most pandemic strain of norovirus in humans that could be utilized for an effective vaccine.
A study has revealed genetic variants associated with differing levels of protective antibodies produced after routine immunizations.
A global genomic survey of Streptococcus pneumoniae has identified 621 strains across 50 countries and has highlighted how the bacteria can evolve in response to vaccination.